IP Library › Granted Patent US 12,268,478
Granted Patent B2
US 12,268,478 · App. 17/188,708 · Granted Apr 8, 2025

Non-cerebral organ autoregulation status determination

Inventors: Paul S. Addison (Edinburgh, GB); Dean Montgomery (Edinburgh, GB); Andre Antunes (Edinburgh, GB)
Assignee: COVIDIEN LP
A61B5/0205A61B5/201A61B5/42A61B5/7267G16H10/60A61B5/021A61B5/14553
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,268,478
App. No.
17/188,708
Granted
Apr 8, 2025
Kind
B2
Abstract

A system for monitoring autoregulation may include processing circuitry configured to receive a blood pressure signal indicative of an acquisition blood pressure of a patient at an acquisition site and an oxygen saturation signal indicative of an oxygen saturation of the patient. The processing circuitry may determine a cerebral autoregulation status value based on the blood pressure signal and the oxygen saturation signal. The processing circuitry may determine a non-cerebral autoregulation status value based on the cerebral autoregulation status value and an adjustment value. The processing circuitry provide to an output device a signal indicative of the non-cerebral autoregulation status value and a signal indicative of the cerebral autoregulation status value to enable a clinician to monitor the autoregulation status of the patient.

Claims (71)

1. A method comprising:

receiving, by processing circuitry, a blood pressure signal indicative of a blood pressure of a patient and an oxygen saturation signal indicative of an oxygen saturation of the patient;

determining, by the processing circuitry, a cerebral autoregulation status value based on the blood pressure signal and the oxygen saturation signal;

determining, by the processing circuitry, an adjustment value based on a relationship between the cerebral autoregulation status value and a non-cerebral autoregulation status value using a neural network algorithm comprising a plurality of nodes by:

inputting at least the cerebral autoregulation status value into the neural network algorithm;

iteratively evaluating an output of the neural network algorithm, wherein the output comprises a non-cerebral autoregulation status value estimate;

iteratively modifying at least one node parameter of the plurality of nodes based on the evaluation of the output of the neural network algorithm to generate a modified neural network algorithm; and

determining the adjustment value based on the modified neural network algorithm;

determining, by the processing circuitry, the non-cerebral autoregulation status value of the patient based on the cerebral autoregulation status value and the adjustment value; and

providing, by the processing circuitry and to an output device, a signal indicative of the non-cerebral autoregulation status value.

2. The method of claim 1 , further comprising determining, by the processing circuitry, a range of adjustment values using a machine learning algorithm or a deep learning algorithm, wherein the range of adjustment values comprises the adjustment value.

3. The method of claim 1 , further comprising determining, by the processing circuitry, the adjustment value based on patient-specific data, the patient-specific data including one or more respective cerebral autoregulation status values and one or more respective non-cerebral autoregulation status values.

4. The method of claim 1 , further comprising determining, by the processing circuitry, the adjustment value based on predetermined associations between cerebral autoregulation status values of a population of patients and non-cerebral autoregulation status values of the population of patients.

5. The method of claim 1 , further comprising determining, by the processing circuitry, an additional adjustment value by at least determining a relationship between the cerebral autoregulation status value and an additional non-cerebral autoregulation status value using a finite element model based on a plurality of finite elements configured to model an association between the cerebral autoregulation status value and the additional non-cerebral autoregulation status value.

6. The method of claim 1 , wherein the adjustment value comprises an offset or a multiplier.

7. The method of claim 1 , further comprising presenting, via a display of the output device, a user interface indicating the non-cerebral autoregulation status value.

8. The method of claim 1 , further comprising presenting, via a display of the output device, a cerebral lower limit of autoregulation (LLA) and a range of adjustment values above the LLA indicative of a range of non-cerebral autoregulation status values determined based on the adjustment value.

9. The method of claim 1 , wherein the non-cerebral autoregulation status value comprises at least one of a lower limit of autoregulation or an upper limit of autoregulation, and wherein the cerebral autoregulation status value comprises at least one of a lower limit of cerebral autoregulation or an upper limit of cerebral autoregulation.

10. The method of claim 1 , wherein the non-cerebral autoregulation status value comprises a kidney autoregulation status value.

11. The method of claim 1 , further comprising:

determining, by the processing circuitry, an autoregulation state of a non-cerebral organ of the patient based on the non-cerebral autoregulation status value; and

presenting, via a display of the output device, an indication of the autoregulation state of the non-cerebral organ.

12. A system comprising:

a blood pressure sensor configured to generate a blood pressure signal indicative of a blood pressure of a patient;

an oxygen saturation sensor configured to generate an oxygen saturation signal indicative of an oxygen saturation of the patient; and

processing circuitry configured to:

receive the blood pressure signal from the blood pressure sensor,

receive the oxygen saturation signal from the oxygen saturation sensor,

determine a cerebral autoregulation status value based on the blood pressure signal and the oxygen saturation signal,

determine an adjustment value based on a relationship between the cerebral autoregulation status value and a non-cerebral autoregulation status value using a neural network algorithm comprising a plurality of nodes by:

inputting at least the cerebral autoregulation status value into the neural network algorithm;

iteratively evaluating an output of the neural network algorithm, wherein the output comprises a non-cerebral autoregulation status value estimate;

iteratively modifying at least one node parameter of the plurality of nodes based on the evaluation of the output of the neural network algorithm to generating a modified neural network algorithm; and

determining the adjustment value based on the modified neural network algorithm;

determine the non-cerebral autoregulation status value based on the cerebral autoregulation status value and the adjustment value, and

provide to an output device a signal indicative of the non-cerebral autoregulation status value.

13. The system of claim 12 , wherein the processing circuitry is configured to determine an additional adjustment value based on a relationship between the cerebral autoregulation status value and an additional non-cerebral autoregulation status value.

14. The system of claim 13 , wherein the non-cerebral autoregulation status value comprises a kidney autoregulation status value and the additional non-cerebral autoregulation status value comprises a gastrointestinal autoregulation status value.

15. The system of claim 12 , wherein the processing circuitry is configured to determine the adjustment value based on patient-specific data, the patient-specific data including one or more respective cerebral autoregulation status values and one or more respective non-cerebral autoregulation status values.

16. The system of claim 12 , wherein the processing circuitry is configured to determine the adjustment value based on predetermined associations between cerebral autoregulation status values of a population of patients and non-cerebral autoregulation status values of the population of patients.

17. The system of claim 12 , wherein the processing circuitry is configured to determine an additional adjustment value using a finite element model based on a plurality of finite elements configured to model an association between the cerebral autoregulation status value and an additional non-cerebral autoregulation status value.

18. The system of claim 12 , wherein the adjustment value comprises an offset or a multiplier.

19. The system of claim 12 , further comprising the output device comprising a display, wherein the processing circuitry is configured to present, via the display, a user interface indicating the non-cerebral autoregulation status value.

20. The system of claim 12 , further comprising the output device comprising a display, wherein the processing circuitry is configured to present, via the display, a cerebral lower limit of autoregulation (LLA) and a range of adjustment values above the LLA indicative of a range of non-cerebral autoregulation status values determined based on the adjustment value.

21. The system of claim 12 , wherein the non-cerebral autoregulation status value comprises at least one of a lower limit of autoregulation or an upper limit of autoregulation, and wherein the cerebral autoregulation status value comprises at least one of a lower limit of cerebral autoregulation or an upper limit of cerebral autoregulation.

22. The system of claim 12 , wherein the non-cerebral autoregulation status value comprises a range of non-cerebral autoregulation status values.

23. The system of claim 12 , wherein the non-cerebral autoregulation status value comprises a kidney autoregulation status value.

24. The system of claim 12 , further comprising the output device comprising a display, wherein the processing circuitry is further configured to:

determine an autoregulation state of a non-cerebral organ of the patient based on the non-cerebral autoregulation status value, and

presenting, via the display, an indication of the autoregulation state of the non-cerebral organ.

25. The system of claim 12 , wherein the processing circuitry is configured to determine a first range of non-cerebral autoregulation status values for a kidney and a second range of non-cerebral autoregulation status values for a gastrointestinal tract, and at least one of the first range of non-cerebral autoregulation status values or the second range of non-cerebral autoregulation status values comprise the non-cerebral autoregulation status value.

26. The system of claim 25 , wherein the processing circuitry is configured to generate a graph comprising a first region corresponding to the first range of non-cerebral autoregulation status values and a second region corresponding to the second range of non-cerebral autoregulation status values.

27. The system of claim 26 , wherein the processing circuitry is configured to overlay the blood pressure signal on the graph.

28. A system comprising:

a display;

a blood pressure sensor configured to generate a blood pressure signal indicative of a blood pressure of a patient;

an oxygen saturation sensor configured to generate an oxygen saturation signal indicative of an oxygen saturation of the patient; and

processing circuitry configured to:

receive the blood pressure signal from the blood pressure sensor,

receive the oxygen saturation signal from the oxygen saturation sensor,

determine a cerebral autoregulation status value based on the blood pressure signal and the oxygen saturation signal,

determine an adjustment value based on a relationship between the cerebral autoregulation status value and a non-cerebral autoregulation status value using a neural network algorithm comprising a plurality of nodes by:

inputting the cerebral autoregulation status value into the neural network algorithm;

iteratively evaluating an output of the neural network algorithm, wherein the output comprises a non-cerebral autoregulation status value estimate;

iteratively modifying at least one node parameter of the plurality of nodes based on the evaluation of the output of the neural network algorithm to generate a modified neural network algorithm; and

determining the adjustment value based on the modified neural network algorithm;

determine an autoregulation state of a non-cerebral organ of the patient based on the cerebral autoregulation status value and the adjustment value, and

present, via the display, an indication of the autoregulation state of the non-cerebral organ.

29. The system of claim 28 , wherein the non-cerebral organ is a kidney.

30. The system of claim 28 , wherein the indication of the autoregulation state comprises an indication of an impaired autoregulation state of the non-cerebral organ.

31. The system of claim 28 , wherein the processing circuitry is configured to generate a graph comprising a plurality of colors indicative of the autoregulation state of the non-cerebral organ.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2021
From: ADDISON, PAUL S.; MONTGOMERY, DEAN; ANTUNES, ANDRE
To: COVIDIEN LP
Reel/Frame 055447/0862 →
Continuity (2)
Continuation 16165108 · Oct 19, 2018
Related Publication 20210177275A1 · Jun 17, 2021
References Cited (63)
US 5743267A · Nikolic et al. · 1998 [cited by applicant]
US 6599251B2 · Chen et al. · 2003 [cited by applicant]
US 6689069B2 · Bratteli et al. · 2004 [cited by applicant]
US 7070566B2 · Medero et al. · 2006 [cited by applicant]
US 7927283B2 · Riobo et al. · 2011 [cited by applicant]
US 8366627B2 · Kashif et al. · 2013 [cited by applicant]
US 8702604B2 · Karamanoglu et al. · 2014 [cited by applicant]
US 9474451B2 · Brady et al. · 2016 [cited by applicant]
US 9861317B2 · Ochs · 2018 [cited by applicant]
US 10542923B2 · Chang et al. · 2020 [cited by applicant]
US 10595790B2 · Itu et al. · 2020 [cited by applicant]
US 10660530B2 · Montgomery et al. · 2020 [cited by applicant]
US 10740638B1 · Annis · 2020 [cited by applicant]
US 10932673B2 · Addison · 2021 [cited by examiner]
US 11026586B2 · Addison et al. · 2021 [cited by applicant]
US 11102304B1 · Jain et al. · 2021 [cited by applicant]
US 20050015009A1 · Mourad et al. · 2005 [cited by applicant]
US 20070156200A1 · Kornet · 2007 [cited by examiner]
US 20070293760A1 · Schaafsma · 2007 [cited by applicant]
US 20090326386A1 · Sethi et al. · 2009 [cited by applicant]
US 20100094112A1 · Heller · 2010 [cited by examiner]
US 20110105912A1 · Widmar et al. · 2011 [cited by applicant]
US 20110201911A1 · Johnson et al. · 2011 [cited by applicant]
US 20150327779A1 · Breskin et al. · 2015 [cited by applicant]
US 20160162786A1 · Grudic · 2016 [cited by examiner]
US 20160196384A1 · Mansi et al. · 2016 [cited by applicant]
US 20160242700A1 · Ferber et al. · 2016 [cited by applicant]
US 20160324425A1 · Addison et al. · 2016 [cited by applicant]
US 20160367197A1 · Addison et al. · 2016 [cited by applicant]
US 20170000395A1 · Addison · 2017 [cited by examiner]
US 20170095161A1 · Addison et al. · 2017 [cited by applicant]
US 20170105631A1 · Addison et al. · 2017 [cited by applicant]
US 20170105671A1 · Borgos · 2017 [cited by applicant]
US 20170196501A1 · Watson et al. · 2017 [cited by applicant]
US 20180014791A1 · Montgomery et al. · 2018 [cited by applicant]
US 20180020991A1 · Aung et al. · 2018 [cited by applicant]
US 20180049649A1 · Addison et al. · 2018 [cited by applicant]
US 20180070831A1 · Sutin et al. · 2018 [cited by applicant]
US 20180110455A1 · Chang et al. · 2018 [cited by applicant]
US 20180249916A1 · Bienek et al. · 2018 [cited by applicant]
US 20180338731A1 · Addison et al. · 2018 [cited by applicant]
US 20190154660A1 · Cafferty · 2019 [cited by examiner]
US 20190328241A1 · Addison et al. · 2019 [cited by applicant]
US 20200107763A1 · Antunes et al. · 2020 [cited by applicant]
US 20200129076A1 · Montgomery et al. · 2020 [cited by applicant]
US 20200146636A1 · Addison · 2020 [cited by applicant]
US 20200187866A1 · Antunes et al. · 2020 [cited by applicant]
US 20200251201A1 · Ilan · 2020 [cited by applicant]
US 20210177275A1 · Addison et al. · 2021 [cited by applicant]
US 20220213558A1 · Levin et al. · 2022 [cited by applicant]
WO 2017001023A1 · 2017 [cited by applicant]
33. Ono, Masahiro et al. Blood Pressure Excursions Below the Cerebral Autoregulation Threshold During Cardiac Surgery are Associated With Acute Kidney Injury. Critical Care Medicine 41(2):p. 464-471, Feb. 2013. | DOI: 1… [cited by examiner]
Addison et al., “Gradient adjustment method for better discriminating correlating and non-correlating regions of physiological signals: application to the partitioning of impaired and intact zones of cerebral autoregula… [cited by applicant]
Malykhina et al., “Digitalization of medical services for detecting violations of cerebrovascular regulation based on a neural network signal analysis algorithm”, Proceedings of the 2nd International Scientific Conferen… [cited by applicant]
U.S. Appl. No. 17/354,811, filed Jun. 22, 2021, naming inventors Montgomery et al. [cited by applicant]
Scheeran et al., “Journal of Clinical Monitoring and Computing 2016 End of Year Summary: Monitoring Cerebral Oxygenation and Autoregulation,” Springer Science and Business Media, Journal of Clinical Monitoring and Compu… [cited by applicant]
Tsalach et al., “Cerebral Autoregulation Real-Time Monitoring,” PLoS ONE vol. 11, No. 8, Aug. 29, 2016, 27 pp. [cited by applicant]
U.S. Appl. No. 17/210,222, filed Mar. 23, 2021, naming inventors Montgomery et al. [cited by applicant]
Prough, MD, et al., “Monitoring the Brain to Save the Kidneys” Publication info: Critical Care Medicine, Feb. 2013, vol. 41, No. 2, pp. 671-673. [cited by applicant]
Chuan et al., “Is Cerebrovascular Autoregulation Associated With Outcomes After Major Noncardiac Surgery? A Prospective Observational Pilot Study,” Acta Anaesthesiologica Scandinavica, Jul. 11, 2018, 10 pp. [cited by applicant]
Mohamadlou et al., “Prediction of Acute Kidney Injury with a Machine Learning Algorithm using Electronic Health Record Data,” Canadian Journal of Kidney Health and Disease, vol. 5, Nov. 22, 2017, 9 pp. [cited by applicant]
Office Action from U.S. Appl. No. 17/354,811, filed Apr. 27, 2023, 18 pp. [cited by applicant]
Response to Office Action dated Apr. 27, 2023 from U.S. Appl. No. 17/354,811, filed Jul. 27, 2023, 17 pp. [cited by applicant]